Szela Mary T, CEO and President of TriSalus Life Sciences, Inc. ($TLSI), made one open market purchase of company shares worth about $125,000 in the last 365 days, with the most recent on February 23, 2026. This ranks her 1960th among 4983 insiders by purchase amount, below the average of $1.5 million across 3.29 transactions. She reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO and President | S | Common Stock | 4358 | $4.13 | 768,931.0000 | 49,964,311 | 0.56% | 0.01% |
| March 17, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO and President | S | Common Stock | 15944 | $3.85 | 752,987.0000 | 49,964,311 | 2.07% | 0.03% |
| Feb. 23, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO and President | P | Common Stock | 30487 | $4.10 | 773,289.0000 | 49,964,311 | 4.10% | 0.06% |
| Nov. 24, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO and President | A | Employee Stock Option (right to buy) | 250000 | $0.00 | 1,578,182.0000 | 49,964,311 | 18.82% | 0.50% |
| Feb. 13, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO and President | A | Common Stock | 125000 | $0.00 | 317,802.0000 | 0 | 64.83% | 0.00% |
| Nov. 24, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO and President | A | Common Stock | 125000 | $0.00 | 442,802.0000 | 49,964,311 | 39.33% | 0.25% |
| Nov. 24, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO and President | A | Common Stock | 300000 | $0.00 | 742,802.0000 | 49,964,311 | 67.75% | 0.60% |
| July 7, 2025 | Absci Corp | $ABSI | Szela Mary T | Director | A | Stock Option (right to buy) | 178400 | $0.00 | 178,400.0000 | 127,333,887 | 9999.99% | 0.14% |
| June 5, 2025 | Kura Oncology, Inc. | $KURA | Szela Mary T | Not found | A | Option to purchase common stock | 28500 | $0.00 | 28,500.0000 | 86,161,000 | 9999.99% | 0.03% |
| Feb. 18, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | A | Common Stock | 21089 | $0.00 | 465,348.0000 | 0 | 4.75% | 0.00% |
| Jan. 30, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 5010 | $5.28 | 444,259.0000 | 0 | 1.14% | 0.00% |
| Jan. 29, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 5030 | $5.03 | 439,249.0000 | 0 | 1.16% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | A | Common Stock | 40000 | $0.00 | 424,677.0000 | 0 | 10.40% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | A | Employee Stock Option (right to buy) | 240000 | $0.00 | 240,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 4826 | $5.42 | 429,503.0000 | 0 | 1.14% | 0.00% |
| Jan. 28, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 4716 | $5.12 | 434,219.0000 | 0 | 1.10% | 0.00% |
| Sept. 13, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 6000 | $5.00 | 384,677.0000 | 0 | 1.58% | 0.00% |
| Sept. 12, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 7520 | $5.20 | 377,382.0000 | 0 | 2.03% | 0.00% |
| Sept. 13, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 1295 | $4.83 | 378,677.0000 | 0 | 0.34% | 0.00% |
| Sept. 10, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | P | Common Stock | 5000 | $4.97 | 369,862.0000 | 0 | 1.37% | 0.00% |
| June 20, 2024 | Omega Therapeutics, Inc. | $OMGAQ | Szela Mary T | Not found | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 55,154,985 | 9999.99% | 0.05% |
| June 5, 2024 | Kura Oncology, Inc. | $KURA | Szela Mary T | Not found | A | Option to purchase common stock | 26000 | $0.00 | 26,000.0000 | 73,229,000 | 9999.99% | 0.04% |
| Feb. 13, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | A | Employee Stock Option (right to buy) | 288750 | $0.00 | 288,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2024 | TriSalus Life Sciences, Inc. | $TLSI | Szela Mary T | CEO AND PRESIDENT | A | Common Stock | 84899 | $0.00 | 364,862.0000 | 0 | 30.33% | 0.00% |
| May 31, 2023 | Kura Oncology, Inc. | $KURA | Szela Mary T | Director | A | Option to purchase common stock | 26000 | $0.00 | 26,000.0000 | 66,990,000 | 9999.99% | 0.04% |